Somatic Mosaicism And Its Role In Localised Epidermolytic Ichthyosis
Published on: November 3, 2025
Somatic Mosaicism And Its Role In Localised Epidermolytic Ichthyosis
Article author photo

Aeman Mumtaz

Doctor of Pharmacy, Pharm D, Punjab University College of Pharmacy

Article reviewer photo

Tarunikaa Muppala

MSc Applied Infectious Disease Epidemiology, UCL

Have you ever encountered someone with unusual streaks or thick skin that appears distinct from the rest? These patches could have been there since birth and never spread beyond their confines. One rare cause of this is a disorder known as localised Epidermolytic Ichthyosis (EI), which occurs when some skin cells carry a genetic mutation that others do not. 

This strange pattern is caused by something called somatic mosaicism, a biological occurrence in which a person's body has a mix of cells with diverse genetic makeups. Knowing this can help explain why certain skin problems only affect specific parts of the body rather than the entire body. It can also help us understand how our skin grows before we are even born.

What is epidermolytic ichthyosis?

The extremely uncommon skin disorder known as epidermolytic ichthyosis is typically present from birth. It frequently results in red, sensitive skin that blisters easily in newborns. The skin gets scaly, dry, and thick with time. This occurs due to defective forms of two genes, KRT1 and KRT10, which produce keratin, a type of protein.1 Keratins are the building blocks that provide our skin's outermost layer with its shape and strength. Incorrectly manufactured keratins cause the skin to become weak and brittle, rupturing with normal friction. Because it is inherited from a parent, the genetic alteration (mutation) is found in every skin cell in the majority of individuals with this disorder. This leads to generalised disease, meaning the whole body is affected to some degree.

Blaschko’s lines: the hidden patterns on our skin

Blaschko’s lines are invisible patterns that cover our skin like a secret map. You can’t see them under normal conditions, but they represent the exact routes our skin cells follow as they spread and multiply during early development in the womb.2 Many skin conditions, including localised epidermolytic ichthyosis, appear along these lines, creating distinctive streaks, swirls, or patches. Understanding these lines helps explain why only certain areas of the skin are affected while others stay completely normal.

Why does localised epidermolytic ichthyosis follow Blaschko’s lines

Localised epidermolytic ichthyosis only affects particular skin patches or streaks, whereas the traditional type of the condition covers the entire body. These patches typically follow recognisable swirling lines and show up on one side of the body. These odd trends aren't coincidental. They follow Blaschko's lines, developing throughout embryonic development due to chromosomal abnormalitie.s3 These patterned lines are the result of skin cells growing and spreading during foetal development. Any genetic mutations that occur in a single skin cell during this period will be carried by all of the cells that develop from it, while the remaining cells will continue to function normally. This is what creates localised patches of abnormal skin surrounded by normal skin. This situation is called somatic mosaicism.

Understanding somatic mosaicism

When a postzygotic mutation results in two genetically different cell groups within an individual, this condition is known as somatic mosaicism. Somatic mosaic mutations, as opposed to hereditary mutations, are not passed on to offspring and may only impact a section of the body. These mutations have been linked to disease, most notably cancer, and impact different genomic regions, from single nucleotides to entire chromosomes. Numerous variables, including the developmental stage at which the mutation takes place, the body parts impacted, and the pathophysiological effect or effects of the mutation, influence the phenotypic outcomes of somatic mosaicism.4 However, one of the cells may occasionally develop a mutation after the initial few cells are created. The cells that develop from those altered cells carry the mutation forward, but the other cells continue to function normally. A mosaic pattern of genetically distinct cells is the result. This is not limited to the skin. Although somatic mosaicism can appear anywhere on the body, its patterns are most noticeable on the skin. This indicates that just a portion of the skin in localised epidermolytic ichthyosis is composed of cells with the keratin gene mutation; the other skin is entirely healthy.

How somatic mosaicism causes localised disease

In a typical inherited disorder, every skin cell has the mutation, so the entire skin barrier is affected. But in mosaic cases, the mutation happens after fertilisation, during early embryonic cell division.

Here is how it works step by step:

  1. A single skin cell develops a new mutation in the KRT1 or KRT10 gene
  2. That cell continues to divide and multiply, making more cells with the same mutation
  3. These cells migrate in specific lines and swirls as the skin forms during early development
  4. The result is distinct streaks or patches of abnormal skin, while the rest of the body has normal skin cells

Because the normal cells still outnumber the affected ones, the disease remains localised and does not spread. This explains why some children are born with narrow streaks or whorled patches of thick, scaly skin on just part of their body, and why the pattern stays the same for life.

What does localised epidermolytic ichthyosis look like?

The skin in the affected area of a baby with localised epidermolytic ichthyosis is typically brittle, blistering, and red at birth. Their skin gets thick, scaly, and warty as they grow older. The migration of skin cells during development is typically mirrored by the linear or spiral pattern of these patches. Crucially, the surrounding skin appears and functions entirely normally. The afflicted patches may thicken and become more scaly during childhood, but they do not eventually spread to other locations. Children with localised EI typically have normal hair, nails, teeth, and sweat glands, and their general health is unaffected, in contrast to some other types of ichthyosis.

How is it diagnosed?

Due to its rarity, localised EI is frequently confused with other skin problems, such as inflammatory skin diseases or linear epidermal nevus. Dermatologists make the diagnosis by closely analysing the lesions' appearance and pattern.5 They might suggest the following if they detect localised EI:

  • Skin biopsy: This involves removing a tiny sample of skin and examining it under a microscope. It typically shows fragile skin layers, clumping of keratin filaments, and thickened outer layers, which are classic signs of epidermolytic ichthyosis
  • Genetic testing: This can confirm mutations in the KRT1 or KRT10 genes. In mosaic cases, the mutation might only be detectable in the affected skin, not in blood cells, because the rest of the body is genetically normal
  • Family history: Mosaic cases are usually new mutations that are not found in other family members

The diagnosis can only be confirmed by direct genetic examination of the afflicted skin due to its patchy appearance.

Can it be passed on to children?

Most people with localised EI do not pass it on, because the genetic change is only in their skin cells and not in their egg or sperm cells. However, in rare cases, the mutation can also be present in the germ cells. This is called gonadal mosaicism6. When this happens, a person with localised disease can have a child with the generalised form, because the mutation is then present in every cell of the baby’s body. This is why genetic counselling can be helpful for anyone diagnosed with localised EI, especially before planning a family. Testing can help estimate the risk of passing it on.

How is it treated?

Although there isn't a cure for epidermolytic ichthyosis, treatment aims to lessen scaling and protect the skin. Treatment for localised EI is typically less complicated than for the generalised variety because it only affects a small area. Treatment options could consist of:

A key component of supportive therapy for localised epidermolytic ichthyosis linked to somatic mosaicism is the consistent application of moisturisers and emollients. These substances relieve xerosis, soften hyperkeratotic plaques, and make it easier to remove adhering scales gently.7 In addition to increasing skin suppleness and texture, they also improve barrier performance, lessen microfissures, and prevent secondary infection or irritation. Regular use ensures more effective long-term illness management by enhancing patient comfort and aesthetics while also enhancing other targeted therapies.

  •  Keratolytic creams

Keratolytic creams are essential for relieving the symptoms of localised epidermolytic ichthyosis, a condition in which thicker, scaly plaques are caused by aberrant keratinisation. Urea, lactic acid, or salicylic acid-enriched formulations gradually break down the thick outer stratum corneum, promoting the removal of extra scales and enhancing skin moisture. In addition to improving skin texture and comfort by addressing hyperkeratosis locally, these medications also support more comprehensive care approaches meant to lessen the condition's somatic mosaicism symptoms.8

  • Topical retinoids

Vitamin A-derived topical retinoids are potent substances that help normalise skin cell turnover and lessen excessive scaling. In cases of localised epidermolytic ichthyosis, they can enhance texture and appearance by encouraging exfoliation and preventing the accumulation of thicker skin. To guarantee both safety and efficacy, these medications must be used carefully and rigorously under medical supervision due to their strength and possible adverse effects.9

  • Infection prevention

Because cracked or blistered skin is so prone to infection, prompt treatment and gentle skincare are crucial. Complications can be minimised by using protective emollients, cleaning frequently with gentle solutions, and treating infections as soon as they appear. Many people can adequately control their symptoms with basic skincare practices and may not need severe drugs because localised epidermolytic ichthyosis is frequently limited in scope.

Why recognising mosaicism matters

Identifying somatic mosaicism is not just a scientific curiosity; it has real benefits:

  • It helps explain why only part of the skin is affected, preventing unnecessary worry about spreading
  • It allows doctors to distinguish localised EI from other similar conditions
  • It provides accurate genetic advice about the small risk of passing the condition to children
  • It contributes to the scientific understanding of how genetic mutations shape the human body

For families, understanding mosaicism can bring peace of mind. It shows that the condition is not contagious, not caused by anything during pregnancy, and usually does not affect general health.

Living with localised epidermolytic ichthyosis

Living with any visible skin condition can be challenging, especially for children. Patches of thick, scaly skin may draw unwanted attention or cause self-consciousness.10 Parents can help by:

  • Explaining the condition gently to their child in simple words
  • Reassuring them that the patches are not harmful or contagious
  • Working with dermatologists to manage symptoms
  • Talking to teachers or caregivers so they understand the condition

As children grow older, they often learn to accept their unique skin patterns as part of who they are. Many lead completely normal, healthy lives without serious complications.

Summary

Localised epidermolytic ichthyosis (EI) is an uncommon but intriguing illustration of how our skin may be shaped by our genes. The localised form results from somatic mosaicism, a post-zygotic mutation that happens during early embryonic development, as opposed to the generalised form, which is caused by inherited mutations in KRT1 or KRT10 and affects the entire body. Blaschko's lines, the developmental "map" of skin cell migration, are followed by discrete patches of delicate, scaly, and frequently linear or whorled skin as a result of this mixture of normal and mutant cells.

Localised EI typically manifests clinically as blistered, red skin in afflicted areas at birth, which eventually develops into thick, warty plaques, while the surrounding skin stays normal. Importantly, because the mutation is not present in every cell, systemic health is typically unaffected, and most cases do not spread. Histopathology, rigorous clinical assessment, and occasionally genetic testing of the afflicted skin are necessary for the diagnosis.

Emollients, keratolytic creams, topical retinoids used sparingly, and infection prevention are the mainstays of treatment. Accurate diagnosis, genetic counselling (because to the slight but actual danger of gonadal mosaicism), and easing family anxieties all depend on the recognition of mosaicism. Although living with localised EI might provide psychological issues, most people can have normal lives with the right care. This disorder emphasises the complexity of skin biology as well as how a single cell mutation can permanently alter the patterns of human skin that are visible.

FAQs

What causes the streaks or patches on my child’s skin?

They are caused by a tiny genetic change in some skin cells, which makes only certain areas thicker, scaly, or fragile.

Are these patches contagious?

No. This condition is not infectious and cannot spread to other people.

Will the patches spread over time?

Usually not. The patches stay in the same place for life and don’t grow to other parts of the body.

Why do the patches have a line or swirl pattern?

The skin follows natural growth patterns called Blaschko’s lines, which guide how skin cells spread during development.

Can this happen to both individuals assigned female at birth (AFAB) and assigned male at birth (AMAB)?

Yes, it can affect anyone, regardless of gender.

Do these patches hurt or cause other health problems?

The patches may blister or feel dry, but overall health is typically normal, and most internal organs are unaffected.

References

  1. Eskin-Schwartz M, Drozhdina M, Sarig O, Gat A, Jackman T, Isakov O, Shomron N, Samuelov L, Malchin N, Peled A, Vodo D. Epidermolytic ichthyosis sine epidermolysis. Am J Dermatopathol [Internet]. 2017 Jun 1 [cited 2025 Sep 20];39(6):440-4. Available from: https://doi.org/10.1097/DAD.0000000000000674
  2. Molho-Pessach V, Schaffer JV. Blaschko lines and other patterns of cutaneous mosaicism. Clin Dermatol [Internet]. 2011 Mar 1 [cited 2025 Sep 20];29(2):205-25. Available from: https://doi.org/10.1016/j.clindermatol.2010.09.012
  3. Jackson R. The lines of Blaschko: a review and reconsideration: observations of the cause of certain unusual linear conditions of the skin. Br J Dermatol [Internet]. 1976 Oct [cited 2025 Sep 20];95(4):349-60. Available from: https://doi.org/10.1111/j.1365-2133.1976.tb00835.x
  4. Freed D, Stevens EL, Pevsner J. Somatic mosaicism in the human genome. Genes (Basel) [Internet]. 2014 Dec 11 [cited 2025 Sep 20];5(4):1064-94. Available from: https://doi.org/10.3390/genes5041064
  5. DiGiovanna JJ, Robinson-Bostom L. Ichthyosis: etiology, diagnosis, and management. Am J Clin Dermatol [Internet]. 2003 Feb [cited 2025 Sep 20];4(2):81-95. Available from: https://doi.org/10.2165/00128071-200304020-00002
  6. Kovaleva NV, Cotter PD. Somatic/gonadal mosaicism for structural autosomal rearrangements: female predominance among carriers of gonadal mosaicism for unbalanced rearrangements. Mol Cytogenet [Internet]. 2016 Jan 28 [cited 2025 Sep 20];9(1):8. Available from: https://doi.org/10.1186/s13039-015-0211-y
  7. Parker J, Scharfbillig R, Jones S. Moisturisers for the treatment of foot xerosis: a systematic review. J Foot Ankle Res [Internet]. 2017 [cited 2025 Sep 20];10(1):9. Available from: https://doi.org/10.1186/s13047-017-0190-9
  8. Chia SY, Tan EC, Wei H, Zhao Y, Koh MJ. Epidermolytic ichthyosis in a child and systematized epidermolytic nevi in the mosaic parent associated with a KRT1 variant. Eur J Med Genet [Internet]. 2021 Nov 1 [cited 2025 Sep 20];64(11):104324. Available from: https://doi.org/10.1016/j.ejmg.2021.104324
  9. DiGiovanna JJ, Mauro T, Milstone LM, Schmuth M, Toro JR. Systemic retinoids in the management of ichthyoses and related skin types. Dermatol Ther [Internet]. 2013 Jan [cited 2025 Sep 20];26(1):26-38. Available from: https://doi.org/10.1111/j.1529-8019.2012.01527.x
  10. Yosipovitch G, Mevorah B, Mashiach J, Chan YH, David M. High body mass index, dry scaly leg skin and atopic conditions are highly associated with keratosis pilaris. Dermatology [Internet]. 2000 Aug 26 [cited 2025 Sep 20];201(1):34-6. Available from: https://doi.org/10.1159/000018425
Share

Aeman Mumtaz

Doctor of Pharmacy, Pharm D, Punjab University College of Pharmacy

Aeman Mumtaz is a 4th-year Doctor of Pharmacy (Pharm D) student at Punjab University College of Pharmacy. She is passionate about pharmacology, clinical research, and medical writing, and aims to contribute to global healthcare through innovative research and impactful scientific communication.

arrow-right